• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不完全的旁系同源基因补偿导致癌症对TRA2A产生选择性依赖。

Incomplete paralog compensation generates selective dependency on TRA2A in cancer.

作者信息

Lee Amanda R, Tangiyan Anna, Singh Isha, Choi Peter S

机构信息

Department of Pathology & Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America.

Cell and Molecular Biology Graduate Group, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America.

出版信息

PLoS Genet. 2025 May 14;21(5):e1011685. doi: 10.1371/journal.pgen.1011685. eCollection 2025 May.

DOI:10.1371/journal.pgen.1011685
PMID:40367120
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12077678/
Abstract

Paralogs often exhibit functional redundancy, allowing them to effectively compensate for each other's loss. However, this buffering mechanism is frequently disrupted in cancer, exposing unique paralog-specific vulnerabilities. Here, we identify a selective dependency on the splicing factor TRA2A. We find that TRA2A and its paralog TRA2B are synthetic lethal partners that function as widespread and largely redundant activators of both alternative and constitutive splicing. While loss of TRA2A alone is typically neutral due to compensation by TRA2B, we discover that a subset of cancer cell lines are highly TRA2A-dependent. Upon TRA2A depletion, these cell lines exhibit a lack of paralog buffering specifically on shared splicing targets, leading to defects in mitosis and cell death. Notably, TRA2B overexpression rescues both the aberrant splicing and lethality associated with TRA2A loss, indicating that paralog compensation is dosage-sensitive. Together, these findings reveal a complex dosage-dependent relationship between paralogous splicing factors, and highlight how dysfunctional paralog buffering can create a selective dependency in cancer.

摘要

旁系同源基因常常表现出功能冗余,使它们能够有效地相互补偿对方的缺失。然而,这种缓冲机制在癌症中经常被破坏,从而暴露出独特的旁系同源基因特异性脆弱性。在这里,我们确定了对剪接因子TRA2A的选择性依赖性。我们发现TRA2A及其旁系同源基因TRA2B是合成致死伴侣,它们作为可变剪接和组成性剪接的广泛且在很大程度上冗余的激活因子发挥作用。虽然单独缺失TRA2A通常由于TRA2B的补偿而无明显影响,但我们发现一部分癌细胞系高度依赖TRA2A。在TRA2A缺失后,这些细胞系在共享剪接靶点上表现出缺乏旁系同源基因缓冲的情况,导致有丝分裂缺陷和细胞死亡。值得注意的是,TRA2B的过表达挽救了与TRA2A缺失相关的异常剪接和致死性,这表明旁系同源基因补偿对剂量敏感。总之,这些发现揭示了旁系同源剪接因子之间复杂的剂量依赖性关系,并突出了功能失调的旁系同源基因缓冲如何在癌症中产生选择性依赖性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1ed/12077678/f04b041c1ccf/pgen.1011685.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1ed/12077678/e1ef901a70c9/pgen.1011685.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1ed/12077678/abf287639d37/pgen.1011685.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1ed/12077678/dcf2a5b7e872/pgen.1011685.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1ed/12077678/67882ea5f772/pgen.1011685.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1ed/12077678/4674c44e318c/pgen.1011685.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1ed/12077678/f04b041c1ccf/pgen.1011685.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1ed/12077678/e1ef901a70c9/pgen.1011685.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1ed/12077678/abf287639d37/pgen.1011685.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1ed/12077678/dcf2a5b7e872/pgen.1011685.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1ed/12077678/67882ea5f772/pgen.1011685.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1ed/12077678/4674c44e318c/pgen.1011685.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1ed/12077678/f04b041c1ccf/pgen.1011685.g006.jpg

相似文献

1
Incomplete paralog compensation generates selective dependency on TRA2A in cancer.不完全的旁系同源基因补偿导致癌症对TRA2A产生选择性依赖。
PLoS Genet. 2025 May 14;21(5):e1011685. doi: 10.1371/journal.pgen.1011685. eCollection 2025 May.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Pharmacological CLK inhibition disrupts SR protein function and RNA splicing blocking cell growth and migration in TNBC.药理学CLK抑制作用会破坏SR蛋白功能并阻断RNA剪接,从而抑制三阴性乳腺癌细胞的生长和迁移。
Breast Cancer Res. 2025 Jul 29;27(1):140. doi: 10.1186/s13058-025-02091-w.
4
Elbow Fractures Overview肘部骨折概述
5
Cardiomyocyte-Specific Long Noncoding RNA Regulates Alternative Splicing of the Triadin Gene in the Heart.心肌细胞特异性长非编码 RNA 调节心脏中三联蛋白基因的可变剪接。
Circulation. 2022 Aug 30;146(9):699-714. doi: 10.1161/CIRCULATIONAHA.121.058017. Epub 2022 Jul 18.
6
RAS mutation-specific signaling dynamics in response to paralog- and state- selective RAS inhibitors.响应旁系同源物和状态选择性RAS抑制剂的RAS突变特异性信号转导动力学
bioRxiv. 2025 Mar 21:2025.02.14.638317. doi: 10.1101/2025.02.14.638317.
7
Splicing factor SF3B1 promotes endometrial cancer progression via regulating KSR2 RNA maturation.剪接因子 SF3B1 通过调节 KSR2 RNA 的成熟促进子宫内膜癌的进展。
Cell Death Dis. 2020 Oct 10;11(10):842. doi: 10.1038/s41419-020-03055-y.
8
SRC kinase isoforms regulate mRNA splicing during neural development.SRC激酶亚型在神经发育过程中调节mRNA剪接。
J Neurosci. 2025 Aug 1. doi: 10.1523/JNEUROSCI.1705-24.2025.
9
Proteomic compensation by paralogs preserves protein interaction networks after gene loss in cancer.旁系同源物的蛋白质组补偿在癌症基因缺失后维持蛋白质相互作用网络。
Mol Syst Biol. 2025 May 28. doi: 10.1038/s44320-025-00122-4.
10
Cancers adapt to their mutational load by buffering protein misfolding stress.癌症通过缓冲蛋白质错误折叠应激来适应其突变负荷。
Elife. 2024 Nov 25;12:RP87301. doi: 10.7554/eLife.87301.

本文引用的文献

1
Transcriptome-wide splicing network reveals specialized regulatory functions of the core spliceosome.转录组范围的剪接网络揭示了核心剪接体的专门调控功能。
Science. 2024 Nov;386(6721):551-560. doi: 10.1126/science.adn8105. Epub 2024 Oct 31.
2
Mitoferrin2 is a synthetic lethal target for chromosome 8p deleted cancers.线粒体铁蛋白 2 是染色体 8p 缺失型癌症的合成致死靶点。
Genome Med. 2024 Jun 17;16(1):83. doi: 10.1186/s13073-024-01357-w.
3
Engineered CRISPR-Cas12a for higher-order combinatorial chromatin perturbations.用于高阶组合染色质扰动的工程化CRISPR-Cas12a
Nat Biotechnol. 2025 Mar;43(3):369-383. doi: 10.1038/s41587-024-02224-0. Epub 2024 May 17.
4
Efficient gene knockout and genetic interaction screening using the in4mer CRISPR/Cas12a multiplex knockout platform.利用 in4mer CRISPR/Cas12a 多重基因敲除平台进行高效的基因敲除和遗传互作筛选。
Nat Commun. 2024 Apr 27;15(1):3577. doi: 10.1038/s41467-024-47795-3.
5
Paralog dispensability shapes homozygous deletion patterns in tumor genomes.旁系同源基因缺失的可代偿性塑造了肿瘤基因组中的纯合缺失模式。
Mol Syst Biol. 2023 Dec 6;19(12):e11987. doi: 10.15252/msb.202311987. Epub 2023 Nov 14.
6
Optimization of Cas12a for multiplexed genome-scale transcriptional activation.用于多重基因组规模转录激活的Cas12a优化
Cell Genom. 2023 Sep 1;3(9):100387. doi: 10.1016/j.xgen.2023.100387. eCollection 2023 Sep 13.
7
TRA2: The dominant power of alternative splicing in tumors.TRA2:肿瘤中可变剪接的主导作用。
Heliyon. 2023 Apr 15;9(4):e15516. doi: 10.1016/j.heliyon.2023.e15516. eCollection 2023 Apr.
8
Targeting synthetic lethal paralogs in cancer.靶向癌症中的合成致死旁系同源基因。
Trends Cancer. 2023 May;9(5):397-409. doi: 10.1016/j.trecan.2023.02.002. Epub 2023 Mar 6.
9
RNA splicing analysis using heterogeneous and large RNA-seq datasets.使用异质和大型 RNA-seq 数据集进行 RNA 剪接分析。
Nat Commun. 2023 Mar 3;14(1):1230. doi: 10.1038/s41467-023-36585-y.
10
Pan-cancer proteomic map of 949 human cell lines.949 个人类细胞系的泛癌症蛋白质组图谱。
Cancer Cell. 2022 Aug 8;40(8):835-849.e8. doi: 10.1016/j.ccell.2022.06.010. Epub 2022 Jul 14.